The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance
Open accessAbstract
Neisseria meningitidis binds factor H (fH), a key regulator of the alternative complement pathway. A ∼29 kD fH-binding protein expressed in the meningococcal outer membrane was identified by mass spectrometry as GNA1870, a lipoprotein currently under evaluation as a broad-spectrum meningococcal vaccine candidate. GNA1870 was confirmed as the fH ligand on intact bacteria by 1) abrogation of fH binding upon deleting GNA1870, and 2) blocking fH binding by anti-GNA1870 mAbs. fH bound to whole bacteria and purified rGNA1870 representing each of the three variant GNA1870 families. We showed that the amount of fH binding correlated with the level of bacterial GNA1870 expression. High levels of variant 1 GNA1870 expression (either by allelic replacement of gna1870 or by plasmid-driven high-level expression) in strains that otherwise were low-level GNA1870 expressers (and bound low amounts of fH by flow cytometry) restored high levels of fH binding. Diminished fH binding to the GNA1870 deletion mutants was accompanied by enhanced C3 binding and increased killing of the mutants. Conversely, high levels of GNA1870 expression and fH binding enhanced serum resistance. Our findings support the hypothesis that inhibiting the binding of a complement down-regulator protein to the neisserial surface by specific Ab may enhance intrinsic bactericidal activity of the Ab, resulting in two distinct mechanisms of Ab-mediated vaccine efficacy. These data provide further support for inclusion of this molecule in a meningococcal vaccine. To reflect the critical function of this molecule, we suggest calling it fH-binding protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blake, M. S., Johnston, K. H., Russell-Jones, G. J., & Gotschlich, E. C. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90320-8 · Cited by 2,136
(2013) · Pediatrics · doi:10.1542/peds.2013-2511 · Cited by 1,845
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,294
Complete Genome Sequence of Neisseria meningitidis Serogroup B Strain MC58
Tettelin, H., Saunders, N. J., Heidelberg, J., Jeffries, A. C., Nelson, K. E., Eisen, J. A., Ketchum, K. A., Hood, D. W., Peden, J. F., Dodson, R. J., et al. (2000) · Science · doi:10.1126/science.287.5459.1809 · Cited by 1,097
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1327 · Cited by 995
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.1.257 · Cited by 684
Ross, S. C., & Densen, P. (1984) · PubMed · Cited by 630
Modulation of the alternative complement pathways by beta 1 H globulin.
Whaley, K., & Ruddy, S. (1976) · The Journal of experimental medicine · doi:10.1084/jem.144.5.1147 · Cited by 583
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
ROSS, S. C., & DENSEN, P. (1984) · Medicine · doi:10.1097/00005792-198409000-00001 · Cited by 550
Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of Serotypes
Frasch, C. E., Zollinger, W. D., & Poolman, J. T. (1985) · Clinical Infectious Diseases · doi:10.1093/clinids/7.4.504 · Cited by 460
Meri, S., & Pangburn, M. K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3982 · Cited by 412
Ram, S., Sharma, A. K., Simpson, S. D., Gulati, S., McQuillen, D. P., Pangburn, M. K., & Rice, P. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.743 · Cited by 398
Self-citationVaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
Masignani, V., Comanducci, M., Giuliani, M. M., Bambini, S., Adu-Bobie, J., Aricò, B., Brunelli, B., Pieri, A., Santini, L., Savino, S., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021911 · Cited by 395
Self-citationNadA, a Novel Vaccine Candidate of Neisseria meningitidis
Comanducci, M., Bambini, S., Brunelli, B., Adu-Bobie, J., Aricò, B., Capecchi, B., Giuliani, M. M., Masignani, V., Santini, L., Savino, S., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020407 · Cited by 351
Self-citationVaccine Potential of the Neisseria meningitidis 2086 Lipoprotein
Fletcher, L. D., Bernfield, L., Barniak, V., Farley, J. E., Howell, A., Knauf, M., Ooi, P., Smith, R. P., Weise, P., Wetherell, M., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.4.2088-2100.2004 · Cited by 332
Activation of the alternative complement pathway due to resistance of zymosan-bound.
Fearon, D. T., & Austen, K. F. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.4.1683 · Cited by 284
Ram, S., McQuillen, D. P., Gulati, S., Elkins, C., Pangburn, M. K., & Rice, P. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.671 · Cited by 278
Self-citationHammerschmidt, S., Müller, A., Sillmann, H., Miihlenhoff, M., Borrow, R., Fox, A., van Putten, J., Zollinger, W. D., Gerardy‐Schahn, R., & Frosch, M. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02641.x · Cited by 250
Genetic Analysis of Meningococci Carried by Children and Young Adults
Claus, H., Maiden, M. C. J., Wilson, D. J., McCarthy, N. D., Jolley, K. A., Urwin, R., Hessler, F., Frosch, M., & Vogel, U. (2005) · The Journal of Infectious Diseases · doi:10.1086/428590 · Cited by 207
Self-citationFrosch, M., Weisgerber, C., & Meyer, T. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1669 · Cited by 194
Localization of the heparin-binding site on complement factor H.
Pangburn, M. K., Atkinson, M. A., & Meri, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55379-5 · Cited by 190
Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation
Jarvis, G. A., & Vedros, N. A. (1987) · Infection and Immunity · doi:10.1128/iai.55.1.174-180.1987 · Cited by 182
Claus, H., Maiden, M. C. J., Maag, R., Frosch, M., & Vogel, U. (2002) · Microbiology · doi:10.1099/00221287-148-6-1813 · Cited by 176
Self-citationPoint mutation in meningococcal por A gene associated with increased endemic disease
McGuinness, B. T., Clarke, I. N., Lambden, P. R., Barlow, A. K., Heckels, J. E., Poolman, J. T., & Jones, D. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)91297-8 · Cited by 171
Assessment of Complement Deficiency in Patients with Meningococcal Disease in the Netherlands
Fijen, C. A. P., Kuijper, E. J., Bulte, M. T. T., Daha, M. R., & Dankert, J. (1999) · Clinical Infectious Diseases · doi:10.1086/515075 · Cited by 163
Ram, S., Mackinnon, F. G., Gulati, S., McQuillen, D. P., Vogel, U. F., Frosch, M., Elkins, C. A., Guttormsen, H., Wetzler, L. M., Oppermann, M., et al. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00114-5 · Cited by 155
Self-citationDeghmane, A., Giorgini, D., Larribe, M., Alonso, J., & Taha, M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02838.x · Cited by 149
Complement deficiency states and meningococcal disease
Figueroa, J. E., Andreoni, J., & Densen, P. (1993) · Immunologic Research · doi:10.1007/bf02918259 · Cited by 144
Complement escape of human pathogenic bacteria by acquisition of complement regulators
Kraiczy, P., & Würzner, R. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.016 · Cited by 143
Properdin deficiency in a family with fulminant meningococcal infections.
Sjöholm, A. G., Braconier, J. H., & Söderström, C. (1982) · PubMed · Cited by 140
Mechanisms of neisserial serum resistance
Vogel, U. F., & Frosch, M. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01469.x · Cited by 138
Self-citationA family with complement factor D deficiency
Biesma, D. H., Hannema, A. J., van Velzen‐Blad, H., Mulder, L., van Zwieten, R., Kluijt, I., & Roos, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112023 · Cited by 122
Binding of the Complement Inhibitor C4bp to Serogroup B Neisseria meningitidis
Jarva, H., Ram, S., Vogel, U. F., Blom, A. M., & Meri, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6299 · Cited by 110
Self-citationTommassen, J., Vermeij, P., Struyvé, M., Benz, R., & POOLMAN, J. T. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1355-1359.1990 · Cited by 109
Swartley, J. S., Liu, L.-J., Miller, Y. K., Martin, L. E., Edupuganti, S., & Stephens, D. S. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.6.1533-1539.1998 · Cited by 87
Neisserial Lipooligosaccharide Is a Target for Complement Component C4b
Ram, S., Cox, A. D., Wright, J. C., Vogel, U. F., Getzlaff, S., Boden, R., Li, J., Plested, J. S., Meri, S., Gulati, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308364200 · Cited by 87
Self-citationComplement-mediated bacterial killing assays
McQuillen, D. P., Gulati, S., & Rice, P. A. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)36013-8 · Cited by 74
Vogel, U. F., Claus, H., Heinze, G., & Frosch, M. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.954-957.1999 · Cited by 53
Self-citationIngwer, I., Petersen, B. H., & Brooks, G. F. (1978) · PubMed · Cited by 40
Pagotto, F., Salimnia, H., Totten, P. A., et al. (2000) · Gene · doi:10.1016/s0378-1119(99)00557-0 · Cited by 36
Vogel, U. F., Claus, H., Heinze, G., & Frosch, M. (1997) · Medical Microbiology and Immunology · doi:10.1007/s004300050059 · Cited by 35
Self-citationWolff, K., & Stern, A. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04437.x-i1 · Cited by 23
Genetic analysis of capsular status of meningococcal carrier isolates
Sadler, F., FOX, A., Neal, K. R., Dawson, M. M., Cartwright, K. A. V., & Borrow, R. (2003) · Epidemiology and Infection · doi:10.1017/s0950268802007987 · Cited by 21
Complement activation in the nasal mucosa following nasal ragweed‐allergen challenge
Mezei, G., Varga, L. Á., Veres, A., et al. (2001) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2001.012004201.x · Cited by 14
Cited by
Bacterial Adhesins in Host-Microbe Interactions
Kline, K. A., Fälker, S., Dahlberg, S., Normark, S., & Henriques-Normark, B. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.011 · Cited by 630
Reverse Vaccinology: Developing Vaccines in the Era of Genomics
Sette, A., & Rappuoli, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.017 · Cited by 559
Lipoproteins of Bacterial Pathogens
Kovacs-Simon, A., Titball, R. W., & Michell, S. L. (2011) · Infection and Immunity · doi:10.1128/iai.00682-10 · Cited by 440
Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
Self-citationSerruto, D., Bottomley, M. J., Ram, S., Giuliani, M. M., & Rappuoli, R. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.033 · Cited by 404
Self-citation
Metadata
- Authors
- Madico, G., Welsch, J. A., Lewis, L. A., McNaughton, A., Perlman, D. H., Costello, C. E., Ngampasutadol, J., Vogel, U., Granoff, D. M., & Ram, S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-07-01
- Volume
- 177
- Issue
- 1
- Pages
- 501-510
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2166663556
- Cited by
- 390
- References
- 45
- FWCI
- 17.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.